View our latest presentations and webcasts.
Corporate Presentation
February 2023
SparingVision poster presentations at the American College of Toxicology’s annual meeting 2022
SparingVision presentations at the European Society for Gene and Cell Therapies’ annual meeting 2022
Chardan’s 6th Annual Genetic Medicines Conference,
October 4-5, 2022 : Company presentation
Jefferies Cell & Genetic Medicine Summit,
September 29, 2022: Company presentation
LifeSci 2nd Annual Genetic Medicines Symposium,
June 2022: Fireside chat
SPVN06 oral presentation at the American Society of Gene and Cell Therapy (ASGCT) 25th Annual Meeting 2022
Gene Independent Approaches to Cone Photoreceptor Function Preservation- e-Poster presentation
Retina World Congress 2022
SPVN06 presentations at the Association for Research in Vision and Ophthalmology 2022 Annual Meeting
Oppenheimer Fireside Chat : The Future of Gene Therapy and Gene Editing in Ophthalmology, January 2022
Intellia Therapeutics and SparingVision Announce Strategic Collaboration
Intellia Therapeutics and SparingVision Announce Strategic Collaboration – webcast
Gamut acquisition webcast
SparingVision announces acquisition of GAMUT Therapeutics
SparingVision Raises €44.5 Million and Appoints Stéphane Boissel as Chief Executive Officer
Menu
Latest Tweets
Excited to be listed by @BioBuzz in their "5 Philly Life Sciences Companies We're Watching in H1 2023." Proud to be part of the thriving #PhillyLifeSciences community! #GenomicMedicines #Ophthalmology #GeneTherapy #GenomeEditing
Read more: https://biobuzz.io/5-philly-life-sciences-companies-were-watching-in-h1-2023/
PARTNERS
